Related Experiment Video
Updated: May 5, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Antenatal Screening for Sexually Transmitted Infections to Reduce Preterm Birth or Low Birthweight (Philani Ndiphile
Andrew Medina-Marino1, Chibuzor M Babalola2, Mandisa M Mdingi3
1Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Insights
Antenatal screening for sexually transmitted infections (STIs) like chlamydia, gonorrhea, and trichomoniasis did not improve overall birth outcomes. However, two-time screening significantly reduced preterm births in pregnant women.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Public Health
Background:
- Sexually transmitted infections (STIs) including *Chlamydia trachomatis*, *Neisseria gonorrhoeae*, and *Trichomonas vaginalis* are linked to adverse birth outcomes.
- Most STIs during pregnancy are asymptomatic, complicating detection and management.
- The efficacy of antenatal STI screening in improving maternal and infant health remains an area of investigation.
Purpose of the Study:
- To evaluate the impact of one-time versus two-time antenatal screening and treatment for common STIs on adverse birth outcomes.
- To compare these screening strategies against standard syndromic management in pregnant women.
Main Methods:
- A randomized controlled trial involving pregnant women in South Africa was conducted.
- Participants were assigned to one-time screening, two-time screening, or standard-of-care (syndromic management).
- The primary outcome was a composite of preterm birth or low birthweight; secondary outcomes included individual components.
Main Results:
- Neither one-time nor two-time antenatal STI screening reduced the composite outcome of preterm birth or low birthweight.
- The two-time screening strategy showed a significant reduction in preterm birth (14.5% vs. 18.8% in standard care).
- No significant difference was observed in low birthweight rates across the groups.
Conclusions:
- Routine antenatal screening for *Chlamydia trachomatis*, *Neisseria gonorrhoeae*, and *Trichomonas vaginalis* did not improve the composite adverse birth outcome.
- A two-time screening approach demonstrated a potential benefit by reducing the incidence of preterm birth.
Background:
Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis are curable sexually transmitted infections (STIs) associated with adverse birth outcomes. Most infections are asymptomatic. Whether antenatal STI screening improves birth outcomes remains uncertain.
Methods:
In a randomized three-group trial in South Africa, pregnant women aged 18 years or older were assigned before 27 weeks' gestation to: (1) screening and treatment for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis at enrollment, with tests-of-cure (One-Time Screening); (2) screening and treatment at enrollment, repeated at 30 to 34 weeks (Two-Time Screening); or (3) Standard-of-Care (Syndromic management). The primary outcome was a composite of preterm birth (<37 weeks' gestation) or low birthweight (<2500 g), analyzed in the modified intention-to-treat population of participants with live births. Components of the composite outcome were evaluated individually as the main secondary outcomes. The study was registered with ClinicalTrials.gov, NCT04446611.
Findings:
Of 2247 enrolled participants, 1910 had live births. The composite outcome occurred in 22·9% of the One-Time Screening group (risk ratio [RR] 0·99; 95% confidence interval [CI] 0·81-1·21), 20·6% of the Two-Time Screening group (RR 0·89; 95% CI 0·72-1·09), compared with 23·2% of the Standard-of-Care group. Preterm birth occurred in 18·9% of the One-Time Screening group (RR 1·00; 95% CI 0·80-1·26), 14·5% of the Two-Time Screening group (RR 0·77; 95% CI 0·60-0·99), and 18·8% of the Standard-of-Care group. Low birthweight occurred in 14·1% of the One-Time Screening group (RR 1·10; 95% CI 0·83-1·46), 12·9% of the Two-Time Screening group (RR 1·01; 95% CI 0·76-1·35), and 12·8% of the Standard-of-Care group.
Interpretation:
Neither screening strategy for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis reduced the primary composite outcome of preterm birth or low birthweight, or low birthweight alone. The Two-Time antenatal STI screening strategy, however, reduced preterm birth by 23%.
Related Concept Videos
Sexually Transmitted Infections
Development of the Oral Microbiota
Preventive Healthcare Services
Regression Toward the Mean

